IRIX vs LASE

For growth investors, IRIDEX Corporation (IRIX) is the stronger pick with -6.

2% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Laser Photonics Corporation (LASE) delivered a total return of -66.

2%, compared to -86. 2% for IRIDEX Corporation (IRIX). Over 10 years, the gap is even starker: LASE returned -66. 2% versus IRIX's -90. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), IRIDEX Corporation (IRIX) is the lower-risk stock at 1.

16β versus Laser Photonics Corporation's 1. 81β — meaning LASE is approximately 56% more volatile than IRIX relative to the S&P 500. On balance sheet safety, Laser Photonics Corporation (LASE) carries a lower debt/equity ratio of 49% versus 2% for IRIDEX Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), IRIDEX Corporation (IRIX) is pulling ahead at -6.

2% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: Laser Photonics Corporation grew EPS 40. 5% year-over-year, compared to 8. 5% for IRIDEX Corporation. Over a 3-year CAGR, IRIX leads at -3. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

IRIDEX Corporation (IRIX) is the more profitable company, earning -18.

3% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps -18. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRIX leads at -17. 1% versus -189. 3% for LASE. At the gross margin level — before operating expenses — LASE leads at 43. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, IRIDEX Corporation (IRIX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

16)). Laser Photonics Corporation (LASE) carries a higher beta of 1. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IRIX: -90. 8%, LASE: -66. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (IRIX (Healthcare) and LASE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.